Fig. 1 · Structure

Documents & Downloads

Clobetasol propionate

Cat. No. A11835 CAS 25122-46-7

anti-inflammatory corticosteroid

Clobetasol propionate is a anti-inflammatory corticosteroid used to treat various skin disorders.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
CYP3A5 IC50 0.206 μM
CYP3A4 IC50 15.6 μM

Cellular Effect

Cell Line Activity Value Description Reference
ASPC1 IC50 0.021 μM Inhibition of CYP3A5 in doxycycline-induced CYP3A5 overexpressing wild type human AsPC1 cells assessed as decrease in 1-hydroxymidazolam formation using midazolam as substrate pretreated with doxycycline for 24 hrs followed by incubation with compound for [PMID: 31965799]
ASPC1 IC50 0.044 μM Inhibition of CYP3A5 in wild type human AsPC1 cells assessed as decrease in 1-hydroxymidazolam formation using midazolam as substrate after 24 hrs by LC-MS/MS analysis [PMID: 31965799]
ASPC1 IC50 0.078 μM Inhibition of CYP3A5 in lentiviral pLVX-TRE3G-ZsGreen1-CYP3A5 transduced wild type human AsPC1 cells overexpressing CYP3A5 assessed as decrease in 1-hydroxymidazolam formation using midazolam as substrate after 24 hrs by LC-MS/MS analysis [PMID: 31965799]
ASPC1 IC50 0.103 μM Inhibition of CYP3A5 in CRISPR/Cas9-mediated CYP3A5 knock-out and doxycycline-induced CYP3A5 overexpressing human AsPC1 cells assessed as decrease in 1-hydroxymidazolam formation using midazolam as substrate pretreated with doxycycline for 24 hrs followed [PMID: 31965799]

Clobetasol propionate Research Summary

This section summarizes 2 in vivo studies of Clobetasol propionate from 1 published reference.

Clobetasol propionate In Vivo Studies

Clobetasol propionate was applied topically before IMQ application in BALB/c mice with IMQ-induced psoriasis. Compared with the IMQ-treated group, treatment significantly reduced the spleen weight to body weight ratio but did not reverse the body weight decrease. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Spleen index in an IMQ-induced psoriasis mouse model

Animal study · BALB/c (Bagg albino strain C) mice; IMQ-induced psoriasis mouse model; n = 6 per group [1]

In BALB/c mice with IMQ-induced psoriasis, clobetasol propionate was applied topically before IMQ application. Treatment significantly reduced the spleen weight to body weight ratio compared with the IMQ-treated group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
ratio of the spleen weight to body weightReported result 0.05% CP: CP significantly reduced the spleen index in IMQ-treated mice (p < 0.05)[1]

Conditions shared by the study groups

Route
topically applied
Treatment course
for 1 h before IMQ application
Vehicle
acetone
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Clobetasol propionate 0.05%IMQ-treated (IMQ)0.05% CP: CP significantly reduced the spleen index in IMQ-treated mice (p < 0.05)[1]
Clobetasol propionate 0.05%
Model: BALB/c (Bagg albino strain C) mice; IMQ-induced psoriasis mouse model; n = 6 per group
Methods and source locations

Compound reported in the paper: Clobetasol propionate

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S1, S10); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S67, S70, S71, S74, S75, S81); Figure 1 legend (S140, S141)

ratio of the spleen weight to body weight: ratio of the spleen weight to body weight; comparator: IMQ-treated (IMQ) — 2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S10); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S71, S81)

Clobetasol propionate 0.05% · 2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S10); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S71, S75)

Body weight in an IMQ-induced psoriasis mouse model

Animal study · BALB/c (Bagg albino strain C) mice; IMQ-induced psoriasis mouse model; n = 6 per group [1]

In BALB/c mice with IMQ-induced psoriasis, clobetasol propionate was applied topically before IMQ application. Treatment did not reverse the body weight decrease compared with the IMQ-treated group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Body weight of mice from five groupsReported result 0.05% CP: this decrease was reversed by treatment with RPE 1% (p < 0.05) but not CP[1]

Conditions shared by the study groups

Route
topically applied
Treatment course
for 1 h before IMQ application
Vehicle
acetone
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Clobetasol propionate 0.05%IMQ-treated (IMQ)0.05% CP: this decrease was reversed by treatment with RPE 1% (p < 0.05) but not CP[1]
Clobetasol propionate 0.05%
Model: BALB/c (Bagg albino strain C) mice; IMQ-induced psoriasis mouse model; n = 6 per group
Methods and source locations

Compound reported in the paper: Clobetasol propionate

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S1, S9); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S67, S70, S71, S74, S75); Figure 1 legend (S138, S140, S141)

Body weight of mice from five groups: Body weight of mice from five groups; comparator: IMQ-treated (IMQ) — 2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S9); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S71); Figure 1 legend (S138)

Clobetasol propionate 0.05% · 2. Results > 2.1. Effects of RPE on Psoriasis-like Symptoms in IMQ-Induced Mice (S9); 4. Materials and Methods > 4.2. Animal Grouping and Treatments (S71, S75)

Specifications

Manufacturer Adooq Bioscience
CAS Number 25122-46-7
Applications anti-inflammatory corticosteroid
Formula C25H32ClFO5
Molecular Weight 466.97
SMILES
C[C@@]12[C@](C(CCl)=O)(OC(CC)=O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 79 mg/mL (169.17 mM)
Water Insoluble
Ethanol 17 mg/mL (36.4 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Clobetasol propionate Research References

  1. [1] Nguyen LTH, Ahn SH, Shin HM, et al. Anti-Psoriatic Effect of Rheum palmatum L. and Its Underlying Molecular Mechanisms. Int J Mol Sci (2022). PMID: 36555642 DOI: 10.3390/ijms232416000 Source material

Added to your cart

View Cart Checkout
Loading...